In a recent study, talk therapy in Parkinson’s disease led to significant improvement in patients' well-being, ...

A nutritionist has said it's 'extremely worrying' that so many people are deficient in a mineral that can be easily obtained ...

The US Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in ...

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, scientists were able to identify patterns of neurodegeneration and create metrics ...

New research shows that inhaling polluted air for just an hour can impair cognitive abilities like attention and emotional ...

On Thursday, Jan. 30, the "Walking in Memphis" hitmaker posted about his Parkinson's disease diagnosis on Instagram and explained why he is sharing the news years later. "I feel like it's time to ...

In a groundbreaking development for neurological care, scientists have unveiled an artificial intelligence-powered blood test that has the potential to detect Parkinson’s disease years before ...

Background: Non-alcoholic fatty liver disease (NAFLD) or liver fibrosis may share similar pathophysiological features with Parkinson’s disease (PD), yet their ... for memory function. Olfactory ...

This is known as olfactory dysfunction. In most cases it's temporary, returning to normal within a few weeks. This is because every few months your olfactory nerve cells die and are replaced by new ...

Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad 382355, Gujarat, India Department of Pharmacology and Toxicology, College of ...

This is known as olfactory dysfunction. In most cases it’s ... including Alzheimer’s and Parkinson’s diseases. Patients frequently report losing their sense of smell years before any ...

More than 96% of patients with Parkinson's disease (PD) present with olfactory dysfunction, compared with an established olfactory loss of at least 25% in the normal population over 52 years of age.